Antiplatelet Drug Resistances and Ischemic Events

NCT00501423 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 771

Last updated 2014-01-31

No results posted yet for this study

Summary

The ADRIE study is an observational study on the clinical relevance of platelet reactivity in aspirin and clopidogrel treated cardiovascular patients.

Conditions

  • Symptomatic Atherothrombosis

Sponsors & Collaborators

  • Beziers Hospital

    collaborator OTHER
  • University Hospital, Montpellier

    collaborator OTHER
  • Ministry of Health, France

    collaborator OTHER_GOV
  • Swiss National Science Foundation

    collaborator OTHER
  • Pierre Fontana

    lead OTHER

Principal Investigators

  • Pierre Fontana, MD PhD · University Hospitals Geneva, Switzerland

  • Jean-Luc Reny, MD PhD · Beziers Hospital, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • France

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00501423 on ClinicalTrials.gov